Please Wait

Applying Filters...

CAS-51-21-8
USDMF
Table View

CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

CAS-51-21-8

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 14 USDMF, 4 CEP/COS, 2 JDMF, 15 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

95 Drugs in Development

95 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

168 FDF Dossiers, 67 FDA Orange Book, 42 Europe, 6 Canada, 28 Australia, 11 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%, SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%, CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 9 DKSH, 1 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 10 BASF, 1 BioSpectra, 1 Clariant, 2 Corel Pharma Chem, 2 Finar, 6 Gangwal Chemicals, 7 Kerry, 2 Lubrizol Life Science Health, 3 Microlex e.U, 2 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 9 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Topical, 22 Solubilizers, 14 Parenteral, 11 Film Formers & Plasticizers, 10 Emulsifying Agents, 9 Coating Systems & Additives, 9 Thickeners and Stabilizers, 9 Fillers, Diluents & Binders, 7 Surfactant & Foaming Agents, 7 Co-Processed Excipients, 5 Direct Compression, 4 Lubricants & Glidants, 3 Controlled & Modified Release, 2 Granulation, 2 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 38 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 46 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

13 APIs, 15 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 5 USP, 6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/11/2024	TAPI Technology & API Services	Israel	TEVA PHARMACEUTICAL INDUSTRIES LTD	3062	5-FLUOROURACIL	1977-11-09	Active	II	Complete	2012-11-30	2012-11-08
28/11/2024	Actylis	U.S.A	PHARMA-WALDHOF GMBH	4959	5-FLUORO-URACIL,PRODUCT 4965	1983-05-18	Inactive	II	N/A

Contact us
to update this info

CAS-51-21-8

CAS-51-21-8

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers

14 USDMF

4 CEP/COS

2 JDMF

15 NDC API

14 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

95 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

168 FDF Dossiers

67 FDA Orange Book

42 Europe

6 Canada

28 Australia

11 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%

SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.5%

CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

9 DKSH

1 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Actylis

10 BASF

1 BioSpectra

1 Clariant

2 Corel Pharma Chem

2 Finar

6 Gangwal Chemicals

7 Kerry

2 Lubrizol Life Science Health

3 Microlex e.U

2 Nanjing Bold Chemical

1 Pluviaendo

4 Roquette

9 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Topical

22 Solubilizers

14 Parenteral

11 Film Formers & Plasticizers

10 Emulsifying Agents

9 Coating Systems & Additives

9 Thickeners and Stabilizers

9 Fillers, Diluents & Binders

7 Surfactant & Foaming Agents

7 Co-Processed Excipients

5 Direct Compression

4 Lubricants & Glidants

3 Controlled & Modified Release

2 Granulation

2 Rheology Modifiers

1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

38 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

46 Finished Drug Prices

1 Annual Reports

MARKET PLACE

13 APIs

15 FDF Dossiers

REF. STANDARDS & IMPURITIES

SOLUTION;TOPICAL - 5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons